Request for Information (RFI) Application Programing Interface (API) Enterprise Management Solutions
ID: FDA-RFI-75F40125Q00052Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

Original Source

https://sam.gov/opp/1182a9f62036460799da199f0ec1a295/view
Timeline
    Description

    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is seeking information regarding Application Programming Interface (API) Enterprise Management Solutions to support its enterprise-wide API strategy. The primary objective of this Request for Information (RFI) is to gather insights on existing or potential solutions that can standardize and streamline the management of APIs currently dispersed throughout the organization, with a focus on scalability, security, and total cost of ownership. This initiative is crucial for modernizing legacy systems and enhancing operational efficiency within the FDA. Interested vendors are encouraged to submit their responses by December 20, 2024, and can direct inquiries to Noah Padilla at Noah.Padilla@fda.hhs.gov.

    Point(s) of Contact
    Noah Padilla
    Noah.Padilla@fda.hhs.gov
    Files
    Title
    Posted
    FDA-RFI-75F40125Q00052_Enterprise Application Programming Interface (API) Management Solutions.pdf
    The FDA's Request for Information (RFI) no. FDA-RFI-75F40125Q00052 aims to gather market insights on potential Application Programming Interface (API) Enterprise Management Solutions to support its enterprise-wide API strategy. The RFI emphasizes the FDA's need for a unified API management platform to standardize and streamline licensing, management, and migration of existing APIs, currently scattered across the organization. Key objectives include identifying qualified vendors, evaluating API scalability and security, and assessing the total cost of ownership. The document outlines expected capabilities, such as multi-cloud integration, API governance, and real-time data services, with a focus on modernizing legacy systems and enhancing operational efficiency. Vendors are requested to provide comprehensive information regarding their offerings, pricing models, and migration support, along with case studies and compliance with relevant security standards. The submission deadline is set for December 20, 2024, with specific guidelines for presenting responses. The RFI is a preliminary step in FDA's market research and does not commit to any contract award or selection process based on submissions.
    Similar Opportunities
    Access to Outpatient Longitudinal Drug Utilization Data
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information from small businesses regarding their capabilities to provide access to outpatient longitudinal drug utilization data. The objective of this procurement is to identify qualified small business sources that can supply existing, HIPAA-compliant data resources to enhance drug safety evaluations, support post-market surveillance, and inform regulatory decisions. This initiative is crucial for improving public health through better data access and analysis capabilities, with a projected contract duration of five years. Interested firms must submit their responses by 10 AM on January 23, 2025, to Telisha Wilson at telisha.wilson@fda.hhs.gov, including their business size status and DUNS number.
    Request for Information (RFI): OII-Extended Reality/Reality Simulation Training & Development Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), has issued a Request for Information (RFI) to explore market capabilities related to Artificial Intelligence-powered Extended Reality (XR) and reality simulation training tools. The FDA aims to enhance the training of its Office of Inspections and Investigations (OII) workforce by integrating immersive learning methods, such as Augmented Reality (AR) and Virtual Reality (VR), to simulate real-world scenarios for effective skill development and performance assessments. This initiative is crucial for modernizing training platforms, improving efficiency, reducing costs, and fostering collaboration among users. Interested parties are encouraged to submit a Capability Statement, limited to 10 pages, detailing their experience and proposed solutions by contacting Vivianna Diaz at Vivianna.Diaz@fda.hhs.gov. Responses must be submitted by the specified deadline, and no late submissions will be accepted.
    FDA Regulated Products Sampling Services
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking qualified vendors to provide Sampling Services for FDA-regulated products through a Sources Sought Notice (Ref No. 75F40125R00032). The primary objective of this procurement is to identify capable businesses that can collect physical samples of food, drugs, medical devices, and other products for laboratory analysis, ensuring safety and verifying labeling accuracy. This initiative is crucial for the FDA's regulatory oversight, as it supports the monitoring of product safety and quality, which may include both domestic and imported goods. Interested parties must submit their responses by January 9, 2025, and can contact Amanda Lusk at Amanda.Lusk@fda.hhs.gov or Nicholas Bisher at Nicholas.Bisher@fda.hhs.gov for further information.
    FY25 Docker Enterprise Edition Licenses
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking proposals for the procurement of Docker Enterprise Edition licenses to support the development of its Containers as a Service (CaaS) platform. The objective of this contract is to enhance the FDA's IT infrastructure by utilizing Docker EE’s container technology, which is essential for improving operational efficiency and reducing costs compared to traditional virtual machines. This procurement is significant as it enables the FDA to deploy applications in various environments while ensuring compliance with federal security mandates. Interested small businesses must submit their quotes by January 2, 2025, and can direct inquiries to Terina Hicks at terina.hicks@fda.hhs.gov or Roosevelt Walker at roosevelt.walker@fda.hhs.gov.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is soliciting proposals through the FY25 Broad Agency Announcement (BAA) aimed at advancing regulatory science and innovation. This opportunity invites organizations, particularly small businesses, to submit research and development proposals that address critical areas such as alternative drug development methods, advanced manufacturing technologies, and predictive toxicology, with a strong emphasis on including diverse populations in research. Proposals must be submitted by February 24, 2025, and will undergo a two-tier evaluation process, with the potential for multiple contracts awarded based on proposal quality and funding availability. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Request for Information - Application Programming
    Active
    Social Security Administration
    The Social Security Administration (SSA) is seeking information regarding Application Programming Interface (API) Management as part of a Request for Information (RFI). This initiative aims to gather insights and responses from industry stakeholders to enhance the SSA's capabilities in managing APIs effectively. The procurement is crucial for ensuring that the SSA can efficiently integrate and manage software applications, which are vital for delivering services to the public. Interested parties can direct their inquiries to Marie Alford at MARIE.ALFORD@SSA.GOV for further details regarding this solicitation.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), has announced the FY24 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to support innovative research projects that enhance regulatory science, with a focus on health, medical, and biotechnology advancements. The awarded contracts, totaling over $24 million, cover a range of critical topics including drug safety, gene therapy, and methodologies for assessing pediatric opioid exposure, reflecting the federal government's commitment to fostering research initiatives that improve healthcare delivery and regulatory processes. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    FY25 Bulk Pharma Buy (Materiel)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (ASPR), is seeking information from vendors regarding the procurement of pharmaceuticals for the Strategic National Stockpile (SNS) under the FY25 Bulk Pharma Buy initiative. The RFI aims to gather details on vendors' capabilities to supply FDA-approved pharmaceuticals, including Amoxicillin, Ciprofloxacin, and Clindamycin, which are critical for public health emergencies. This procurement is vital for ensuring rapid access to life-saving medical supplies during biological, chemical, and radiological threats, as well as natural disasters. Interested vendors must submit their responses electronically by January 8, 2025, and can direct inquiries to Terri Reed at terri.reed@hhs.gov.
    Request for Information - Enhancing Pharmacy Countermeasures in Independent Pharmacies
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking insights through a Request for Information (RFI) aimed at enhancing pharmacy countermeasures in independent pharmacies. The objective is to gather information from pharmacy partners, vendors, and associations regarding the necessary capabilities and infrastructure for independent pharmacies to effectively deliver health services, including testing, vaccines, and therapeutics, particularly to under-resourced populations. This initiative is crucial as independent pharmacies play a vital role in public health, especially in rural areas, and the information collected will inform strategies to improve service delivery and public health response capacity. Interested parties can contact Dawn Redman at dredman@cdc.gov or call 404-498-3069 for further details.